£2.6M
Clean Growth Fund backed the biotechnology spin-out as it prepares to scale commercial operations.
HydRegen develops bio-based catalysts to enable cleaner manufacturing processes in the chemical and pharmaceutical industries.
Oxford-based biotechnology company developing bio-based catalysts for cleaner manufacturing in the pharmaceutical and chemical sectors.
Holly Reeve
CEO
Sarah Cleary
Clean Growth Fund backed the biotechnology spin-out as it prepares to scale commercial operations.